Toyonori Omori Selected Research

Toyonori Omori Research Topics

3	Malignant Mesothelioma 12/2019 - 07/2015
2	Neoplasms (Cancer) 12/2019 - 07/2016
2	Inflammation (Inflammations) 12/2019 - 07/2014
2	Stroke (Strokes) 01/2015 - 11/2011
2	Mesothelioma 07/2014 - 12/2012
2	Osteoporosis 12/2011 - 01/2010
1	Threatened Abortion 04/2019
1	Venous Thromboembolism 04/2019
1	Infections 01/2019
1	Stillbirth 01/2019
1	Hydrothorax 07/2015
1	Asbestosis 07/2015
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Pleural Diseases 07/2014
1	Carcinogenesis 01/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Hyperplasia 01/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2014
1	Postmenopausal Osteoporosis 12/2011
1	Bone Resorption 12/2011
1	Metabolic Bone Diseases (Osteopenia) 01/2010

5	AsbestosIBA 12/2019 - 12/2012
3	Carbon Nanotubes (Carbon Nanotube)IBA 07/2016 - 12/2012
2	IsoflavonesIBA 12/2011 - 01/2010
1	ChemokinesIBA 12/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	LigandsIBA 12/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2019
1	ORALIT (ORS)IBA 01/2019
1	Chemokine CCL3IBA 07/2015
1	Unithiol (DMPS)IBA 01/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 07/2014
1	Zinc Oxide FDA Link 01/2014
1	diisopropanolnitrosamineIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 12/2011
1	deoxypyridinolineIBA 12/2011
1	OsteocalcinIBA 12/2011
1	Alkaline PhosphataseIBA 12/2011
1	SaltsIBA 11/2011

2	Cesarean Section (Caesarean Section) 04/2019 - 01/2019
1	Therapeutics 12/2019
1	Secondary Prevention 01/2015